Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help of her friends and family.

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

Karpiak explains how her flexible schedule enables her to succeed at work while staying active in her community.